"So we have a vaccine now in clinical trials, a vaccine that we hope will advance to the clinic soon, a Hookworm vaccine in clinical trials, a new vaccine that's moving into the clinic. I like to say that these are the most important diseases that you've never heard of. These are some of the most common afflictions of the world's population, but they mostly occur among people who live in extreme poverty... [S]o there is no model to figure out who's going to pay for them. So as a consequence, neither the biotechs nor the big pharmaceutical companies make those vaccines."
Quote Details
Added by wikiquote-import-bot
Unverified quote
0 likes
Academics from the United StatesJews from the United StatesYale University alumniScientists from the United StatesPeople from Hartford
Original Language: English
Available Languages (1)
Sources
Imported from EN Wikiquote
https://en.wikiquote.org/wiki/Peter_Hotez
Revision History
No revisions have been submitted for this quote.
Categories
Peter Hotez
25 quotes on TrueQuotesView all quotes by Peter Hotez →
Related Quotes
"Peter Hotez and his wife, Ann, have an autistic daughter, Rachel. ...[W]hen anti-vaccinators impugn vaccines as the c…"
"There's still no road map for what you do to make a vaccine in the midst of a devastating public health outbreak."
"The reason why we have this situation now with Omicron... is we allowed large unvaccinated populations in low- and mi…"
"We invite scientists from all over the world to come into our vaccine labs to learn how to make vaccines under a qual…"
"In 2006, I became founding editor in chief of PLOS Neglected Tropical Diseases, a then new journal for a growing comm…"
"In 2011, together with a team of 15 scientists, I relocated to Houston, Texas, to launch a new school devoted to pove…"
"Today, the NTDs represent the most common afflictions of people who live in extreme poverty. These ailments include d…"
"Baylor's National School of Tropical Medicine... includes as its research arm a... product development partnership (P…"
"One reason... to move our scientists to Houston was to take advantage of being located within the [TMC]... comprising…"
"The big pharma companies are still not going in. Some of the biotechs are starting to, because they're trying to real…"